Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

NeuroMetrix, Inc. NURO NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
43/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

NeuroMetrix, Inc. (NURO) — Analyst outlook / Analyst consensus target is. Based on 2 analyst ratings, the consensus is bullish — 2 Buy.

NURO Analyst Ratings

Buy
2
Ratings
2 Buy
Based on 2 analysts giving stock ratings to NeuroMetrix, Inc. in the past 3 months
Rating breakdown
Buy
2 100%
100%
Buy
2 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

People Also View

OPGN
OPGN
OpGen, Inc.
$23.91
+64.36%
 IINN
IINN
Inspira Technologies Oxy B.H.N. Ltd.
$0.48
-6.50%
 VVOS
VVOS
Vivos Therapeutics, Inc.
$1.35
+10.66%
 SINT
SINT
Sintx Technologies, Inc.
$2.80
-2.44%
 TLIS
TLIS
Talis Biomedical Corporation
$2.84
+0.00%
 HSCS
HSCS
Heart Test Laboratories, Inc.
$1.97
-0.76%
 RMED
RMED
Ra Medical Systems, Inc.
$0.59
+10.00%
 RSLS
RSLS
ReShape Lifesciences Inc.
$3.92
+22.50%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message